Item 8.01 Other Events.

On November 11, 2009, the Registrant's wholly-owned subsidiary, Endo Pharmaceuticals Inc. ("Endo") reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. Endo has agreed to make a one-time, $23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No. Description

99.1 Endo Pharmaceuticals Holdings Inc. Press Release dated November 11, 2009

---